NCT03524963View on ClinicalTrials.gov

Comparative Pharmacokinetic Study Between Two Extended-Release Cilostazol Formulations in Korea

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 7, 2017

Primary Completion Date

May 30, 2018

Study Completion Date

June 30, 2018

Conditions
Peripheral Artery Disease
Interventions
DRUG

Cilostan CR Tab.

Cilostan CR Tab. 200mg once a day for 5 days

DRUG

Pletaal SR Cap.

Pletaal SR Cap. 200mg once a day for 5 days

Trial Locations (1)

13496

CHA Bundang Medical Center, Seongnam

All Listed Sponsors
lead

Bundang CHA Hospital

OTHER

NCT03524963 - Comparative Pharmacokinetic Study Between Two Extended-Release Cilostazol Formulations in Korea | Biotech Hunter | Biotech Hunter